Bard Associates’s Modular Medical MODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$458K Buy
101,744
+2,254
+2% +$10.3K 0.1% 97
2026
Q1
$525K Buy
99,490
+1,884
+2% +$20.2K 0.13% 88
2025
Q4
$1.07M Sell
97,606
-6,644
-6% -$97.6K 0.27% 74
2025
Q3
$2.19M Buy
104,250
+589
+0.6% +$12.7K 0.58% 57
2025
Q2
$2.32M Buy
103,661
+32,155
+45% +$860K 0.74% 49
2025
Q1
$2.34M Sell
71,506
-243
-0.3% -$8.1K 0.87% 41
2024
Q4
$2.95M Buy
71,749
+22,985
+47% +$1.33M 1% 33
2024
Q3
$3.29M Buy
48,764
+21,877
+81% +$1.18M 1.12% 25
2024
Q2
$1.27M Sell
26,887
-580
-2% -$28.4K 0.49% 74
2024
Q1
$1.52M Buy
+27,467
New +$1.48M 0.55% 68

Other funds holding MODD

Bard Associates's MODD Position: Q2 2026 in Review

Bard Associates increased its Modular Medical (MODD) stake by 2.3% in Q2 2026, buying an estimated $10.3K and bringing the position to 101,744 shares worth $458K. The position accounts for 0.1% of the portfolio, ranked #97.

Bard Associates first reported a position in MODD in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.29M in Q3 2024. 20 funds tracked by Wall St. Rank hold MODD as of Q2 2026.

  • Bard Associates held 101,744 shares of Modular Medical worth $458K as of Q2 2026.
  • Bard Associates bought 2,254 Modular Medical shares in Q2 2026, an estimated $10.3K.
  • Modular Medical made up 0.1% of Bard Associates's portfolio in Q2 2026, its #97 holding.
  • Bard Associates first reported a position in Modular Medical in Q1 2024 and has held it in 10 quarters since.
  • Bard Associates's Modular Medical position peaked at $3.29M in Q3 2024.
  • 20 funds tracked by Wall St. Rank held Modular Medical as of Q2 2026.

Based on Bard Associates's 13F filing for Q2 2026, filed 12 Aug 2026.